|
Angiotech Pharmaceuticals, Inc. and its corporate partner, Boston Scientific Corporation have jointly received the Canadian American Business Council (CABC) 2005 Achievement Award, which recognizes innovative and successful alliances between Canadian and American firms.
iCo Therapeutics, Allon Therapeutics and Inimex Pharmaceuticals Inc. have been named 2005/2006 finalists for Canada's Top 10 Life Science Companies Competition. Read the full press release.
CANTEST has been named by BC Business Magazine as one of the Top 25 companies to work for in British Columbia Read the full press release.
The Licensing Executives Society (U.S.A. and Canada) has selected the LES Vancouver Chapter as a recipient of its 2004/2005 Outstanding Chapter Award. The award was due in no small part to the high levels of attendance at LES Vancouver Chapter events/workshops over the past year, and not just the content of the events/workshops themselves.
CANTEST announced that Dr. Donald Rix has won the Ernst & Young Entrepreneur Of The Year® 2005 Pacific Region award in the Health Sciences category. Dr. Rix also received a special citation at the Entrepreneur of the Year National award dinner in Ottawa, recognizing him as a Promoter of Entrepreneurship.
Read the full press release (Entrepreneur of the Year Pacific Region) Read the full press release (Promoter of Entrepreneurship)
enGene Inc. named recipient of the 2005 Excellence in Research of the Year Award by Frost & Sullivan Read the full press release
QSV Biologics Ltd. has been awarded the prestigious 2005 Excellence in Customer Value Enhancement (CVE) best practices award from Frost & Sullivan. |